Bristol-Myers Squibb to Take Part in UBS Global Healthcare Conference

NEW YORK–(BUSINESS WIRE)– Bristol-Myers
Squibb Company (NYSE: BMY) will take part in the UBS Global
Healthcare Conference on Monday, May 22, 2017, in New York. Murdo
Gordon, executive vice president, head of Commercial, will answer
questions about the company at 10 a.m. EDT.

Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,
Twitter,
and YouTube.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170516005260/en/